Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, administered as a once-weekly subcutaneous injection
Achieve your weight goals with holistic support Your healthcare provider is your best resource when considering Semaglutide or Tirzepatide after gallbladder removal
With results from six randomized controlled trials, three systematic reviews, and more than 40,000 patients, the study is the first synthesis of its kind
If you have health insurance through your job, weight loss drug coverage will usually depend on your employer's rules, rather than the insurance company
Wegovy is FDA-approved for supporting weight loss in individuals who meet one of the following criteria: Have obesity, defined as a body mass index (BMI) of 30 kg/m or higher, or